• 1
    Fine J D, Johnson L B, Suchindran C et al. Cancer and inherited epidermolysis bullosa: lifetable analyses of the national epidermolysis bullosa registry study population. In: FineJ D, BauerE A, McGuireJ, MoshellA, eds. Epidermolysis Bullosa. Baltimore: The Johns Hopkins University Press, 1999: 175192.
  • 2
    Arbiser J L, Fan C Y, Su X et al. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. J Invest Dermatol 2004: 123: 788790.
  • 3
    Ryan K M, Vousden K H. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 1998: 18: 36923698.
  • 4
    Hollowood A D, Lai T, Perks C M, Newcomb P V, Alderson D, Holly J M. IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer 2000: 88: 336341.
  • 5
    Mallipeddi R, Wessagowit V, South A P et al. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2004: 122: 13021309.
  • 6
    Cooper H L, Cook I S, Theaker J M et al. Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas. British J Dermatol 2004: 151: 540545.
  • 7
    Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype/genotype correlations in the dystrophic subtypes. J Med Genet, Epub ahead of print 2006: 44: 181192.
  • 8
    Ortiz-Urda S, Garcia J, Green C L et al. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 2005: 307: 17731776.
  • 9
    Pourreyron C, Jones C, Volz A et al. Patients with recessive dystrophic epidermolysis bullosa develop squamous cell carcinoma regardless of type VII collagen NC1 domain expression. J Invest Dermatol 2006: 126 (Suppl. 3): s32.
  • 10
    Campbell C, Quinn A G, Rees J L. Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer. British J Dermatol 1993: 128: 111114.
  • 11
    Pierceall W E, Goldberg L H, Tainsky M A, Mukhopadhyay T, Ananthaswamy H N. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991: 4: 196202.
  • 12
    Rumsby G, Carter R L, Gusterson B A. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 1990: 61: 365368.
  • 13
    Van Der Schroeff J G, Evers L M, Boot A J, Bos J L. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 1990: 94: 423425.
  • 14
    Clark L J, Edington K, Swan I R et al The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Br J Cancer 1993: 68: 617620.
  • 15
    Martinez-Salgado C, Fuentes-Calvo I, Garcia-Cenador B, Santos E, Lopez-Novoa J M. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp Cell Res 2006: 312: 20932106.
  • 16
    Sakai N, Waterman E A, Nguyen N E et al. Laminin 5 beta 3 chain promotes epidermal carcinogenesis through type VII collagen binding and PI3-kinase activation. J Invest Dermatol 2006: 126: 24.
  • 17
    Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne P H, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997: 16: 27832793.
  • 18
    Kennedy S G, Wagner A J, Conzen S D et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997: 11: 701713.
  • 19
    Chan T O, Rodeck U, Chan A M et al. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell 2002: 1: 181191.
  • 20
    Nguyen B P, Gil S G, Carter W G. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem 2000: 275: 3189631907.
  • 21
    Zahir N, Lakins J N, Russell A et al. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 2003: 163: 13971407.